SEER Q1 2024 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-24.4% YoY

Gross Profit

-$133,000-4.3% margin

Operating Income

-$25M-821.7% margin

Net Income

-$21M-674.5% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

-26.7%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$11M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$422M

Total Liabilities

$38M

Stockholders' Equity

$384M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-24.4%
Gross Profit	-$133,000	$762,000	-117.5%
Operating Income	-$25M	-$27M	+8.2%
Net Income	-$21M	-$24M	+13.7%